We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Heron Therapeutics
HRTX
$92.9M
| $1.21M | ﹤0.01% |
287,280
-639
| -0.2% | -$2.5K |
|
2627
First Internet Bancorp
INBK
$255M
| $1.21M | ﹤0.01% |
35,758
+944
| +3% | +$34.4K |
|
2628
RLX Technology
RLX
$2.46B
| $1.21M | ﹤0.01% |
1,153,568
-11,100
| -1% | -$17K |
|
|
BHR
2629
Braemar Hotels & Resorts
BHR
$142M
| $1.21M | ﹤0.01% |
281,490
-79,239
| -22% | -$402K |
|
2630
BrightView Holdings
BV
$1.07B
| $1.21M | ﹤0.01% |
151,964
+975
| +0.6% | +$10.4K |
|
2631
OneSpan
OSPN
$618M
| $1.21M | ﹤0.01% |
140,154
-1,909
| -1% | -$20.6K |
|
2632
Custom Truck One Source
CTOS
$2.37B
| $1.21M | ﹤0.01% |
206,984
-3,051
| -1% | -$19K |
|
2633
Alerus Financial
ALRS
$828M
| $1.21M | ﹤0.01% |
54,527
-990
| -2% | -$23.4K |
|
|
MOFG
2634
DELISTED
MidWestOne Financial Group
MOFG
| $1.2M | ﹤0.01% |
43,952
-1,224
| -3% | -$37.4K |
|
2635
908 Devices
MASS
$364M
| $1.2M | ﹤0.01% |
72,775
+7,744
| +12% | +$150K |
|
2636
Ring Energy
REI
$339M
| $1.2M | ﹤0.01% |
515,861
+216,837
| +73% | +$592K |
|
2637
Saga Communications
SGA
$63.9M
| $1.2M | ﹤0.01% |
45,680
| – | – |
|
|
HTB
2638
HomeTrust Bancshares
HTB
$848M
| $1.19M | ﹤0.01% |
54,006
+58
| +0.1% | +$1.4K |
|
|
SWI
2639
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.19M | ﹤0.01% |
153,653
-2,229
| -1% | -$21.4K |
|
2640
4D Molecular Therapeutics
FDMT
$562M
| $1.18M | ﹤0.01% |
146,201
-314
| -0.2% | -$2.84K |
|
|
SNCY
2641
DELISTED
Sun Country Airlines
SNCY
| $1.17M | ﹤0.01% |
85,997
-13,896
| -14% | -$260K |
|
2642
Insteel Industries
IIIN
$625M
| $1.17M | ﹤0.01% |
43,977
-6,985
| -14% | -$217K |
|
2643
Fiverr
FVRR
$339M
| $1.17M | ﹤0.01% |
38,128
+2,322
| +6% | +$82.5K |
|
2644
Global Industrial
GIC
$1.49B
| $1.16M | ﹤0.01% |
43,282
-6,801
| -14% | -$214K |
|
2645
Republic Bancorp
RBCAA
$1.95B
| $1.16M | ﹤0.01% |
30,312
-551
| -2% | -$24.5K |
|
|
HLTH
2646
DELISTED
Cue Health Inc. Common Stock
HLTH
| $1.16M | ﹤0.01% |
384,991
-132,045
| -26% | -$468K |
|
|
KALV
2647
DELISTED
KalVista Pharmaceuticals
KALV
| $1.16M | ﹤0.01% |
79,778
+535
| +0.7% | +$7.48K |
|
2648
Artesian Resources
ARTNA
$358M
| $1.15M | ﹤0.01% |
23,975
-409
| -2% | -$21.7K |
|
2649
West Bancorporation
WTBA
$485M
| $1.15M | ﹤0.01% |
55,445
-249
| -0.4% | -$6K |
|
|
ROVR
2650
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.15M | ﹤0.01% |
345,466
-5,749
| -2% | -$22.9K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.